<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:15:01" record="39007" source="Espacenet">
	<entities>
		<entity ref="Patent39007" type="Patent">
			<semanticIdentifier>brcris::49f2862c6ca192ce0e2a46a76f72615b</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013001809A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102013001809</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013001809A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20131001809</semanticIdentifier>
			<semanticIdentifier>original::BRBR 10 2013 001809-0</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102013001809"/>
			<field name="identifier.lattes" value="2936919752891302"/>
			<field name="identifier.espacenet" value="102013001809"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="COMPOSTOS 2-CLORO-4-ANILINO-QUINAZOLINICOS INIBIDORES DE PROTEÍNAS TIROSINA CINASES, COMPOSIÇÕES FARMACÊUTICAS COMPREENDENDO OS MESMOS, PROCESSO PARA SUA PRODUÇÃO E MÉTODO PARA INIBIÇÃO DE TIROSINA CINASES"/>
			<field name="title.lattes" value="COMPOSTOS 2-CLORO-4-ANILINO-QUINAZOLINICOS INIBIDORES DE PROTEÍNAS TIROSINA CINASES, COMPOSIÇÕES FARMACÊUTICAS COMPREENDENDO OS MESMOS, PROCESSO PARA SUA PRODUÇÃO E MÉTODO PARA INIBIÇÃO DE TIROSINA CINASES"/>
			<field name="depositDate" value="2013-01-24"/>
			<field name="publicationDate" value="2014-09-09"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="CARLOS MAURICIO RABELLO DE SANT'ANNA"/>
			<field name="inventor" value="ELIEZER JESUS DE LACERDA BARREIRO"/>
			<field name="inventor" value="LIDIA MOREIRA LIMA"/>
			<field name="inventor" value="MARIA LETICIA DE CASTRO BARBOSA"/>
			<field name="inventor" value="ROBERTA TESCH"/>
			<field name="inventor" value="STEFAN ANDREAS LAUFER"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DO RIO DE JANEIRO UFRJ"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K31/517AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="517AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61P35/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="35"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="C07D239/72AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="239"/>
				<field name="subgroup" value="72AI"/>
			</field>
			<field name="abstract.espacenet" value="COMPOSTOS 2-CLORO-4-ANILINO-QUINAZOLINICOS INIBIDORES DE PROTEÍNAS TIROSINA CINASES, COMPOSIÇÕES FARMACÊUTICAS COMPREENDENDO OS MESMOS, PROCESSO PARA SUA PRODUÇÃO E MÉTODO PARA INIBIÇÃO DE TIROSINA CINASES. A presente invenção é relacionada a derivados 2-cloro-4-anilinoquinazolínicos que apresentam atividade inibidora de proteína tirosina cinase EGFR e/ou VEGFR-2, a composições farmacêuticas antitumorais compreendendo tais compostos, e processos para a produção dos mesmos. A presente invenção ainda proporciona um método tratamento de tumores sólidos devido à propriedade de inibição das tirosina cinases."/>
			<field name="originatesFrom" value="51226769"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013001809"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102013001809"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013001809"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20131001809"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR 10 2013 001809-0"/>
				<field name="kind" value=""/>
			</field>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=WO2014113859"/>
		</entity>
		<entity ref="Person26675" type="Person">
			<semanticIdentifier>lattes::2936919752891302</semanticIdentifier>
			<field name="identifier.lattes" value="2936919752891302"/>
			<field name="name" value="Roberta Tesch"/>
		</entity>
		<entity ref="Patent39008" type="Patent">
			<semanticIdentifier>epodoc::WO2014113859</semanticIdentifier>
			<field name="countryCode" value="WO"/>
			<field name="originatesFrom" value="51226769"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="WO"/>
				<field name="number" value="WO2014113859"/>
				<field name="kind" value=""/>
			</field>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent39007" toEntityRef="Person26675" type="Inventor"/>
	</relations>
</entity-relation-data>
